Fezolinetant Reduces Vasomotor Symptoms Associated With Menopause
Fezolinetant is designed to reduce the frequency and severity of VMS associated with menopause by inhibiting neurokinin B binding on the kisspeptin/neurokinin/dynorphin neuron.
Menopause
Sexual Dysfunction in Perimenopause May Be Rooted in Psychosocial Stressors
Sexual dysfunction during perimenopause among women prescribed hormone replacement therapy may have more to do with psychosocial factors, not menopausal symptoms.
FSH Levels in Older Postmenopausal Women Affect Bone and Body Composition
The objective of this study was to investigate the associations between endogenous FSH levels and BMD, BMA, and body composition in older adults, independent of estradiol and testosterone levels.
No Decrease in Pregnancy Rates After Radioactive Iodine Therapy
The aim of this study was to evaluate the possible effects of radioactive iodine therapy on ovarian function and fertility in women.
AHA Scientific Statement on Prevention of CVD Risk During Menopause Transition
Scientific statement by AHA detailing the current understanding of menopause transition and its impact on the risk for postmenopausal cardiovascular disease.
CVD Risk Increased With Multiple Menopausal Symptoms
Having two or more moderate or severe menopausal symptoms (MS) is associated with an increased risk for stroke and cardiovascular disease.
Hypertensive Disorders of Pregnancy May Increase Future Risk for Bothersome Menopausal Symptoms
Perimenopausal women with a history of hypertensive disorders may be candidates for anticipatory guidance for menopause symptom management.
Severe Vasomotor Symptoms at Menopause Associated With CVD Risk
Among women with menopausal vasomotor symptoms, severity rather than frequency of hot flushes and night sweats is associated with an increased risk for CVD.
Medication Use Linked to Weight Gain in Postmenopausal Women
For postmenopausal women, antidepressants, beta-blockers, and insulin are associated with weight gain over three years.
Role of Allopregnanolone in Menstrually Related and Postmenopausal Migraine
Serum allopregnanolone levels are lower in women with either menstrually related or postmenopausal migraine compared with women without headache.
-
Loading...
-
Loading...
Next post in General Endocrinology
